Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06362538

The Cardiovascular Prevention Program

Cardiovascular Prevention Program at Maria Cecilia Hospital

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Maria Cecilia Hospital · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths respectively. In Italy, the situation in terms of deaths due to cardiovascular diseases it is in line with the world ranking and European, being responsible for 44% of all deaths. The only interventional or pharmacological approach is neither effective nor sustainable. The most deaths from cardiovascular diseases are due to atherothrombotic events, which are attributable to a series of risk factors, most of which are modifiable. Turns out itself as a targeted action on these factors with the aim of safeguarding the state of health cardiovascular, may represent the best applicable strategy. It is therefore necessary structure and activate prevention programs aimed at the general population and groups of subjects at higher risk.

Conditions

Interventions

TypeNameDescription
OTHERInternational Physical Activity QuestionnaireAssessments of physical activity level and functional capabilities (aerobic capacity, muscular strength and power, flexibility
OTHERSix minute walking testThe 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
OTHERSF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21.Evaluation of the quality of life, the psychological sphere (anxiety, stress, depression) and the quality of sleep
OTHERMEDASEvaluation of adherence to the Mediterranean diet
OTHERIntima-media thickness (IMT)Bmode ultrasonography
BIOLOGICALBlood samplingMeasurement of parameters for defining cardiovascular risk and biomarkers.
BIOLOGICALStool Sample Culture TestEvaluation of Gut Microbiota

Timeline

Start date
2024-05-13
Primary completion
2027-04-15
Completion
2027-04-15
First posted
2024-04-12
Last updated
2024-08-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06362538. Inclusion in this directory is not an endorsement.